Product
LEO 90100
1 clinical trial
1 indication
Indication
PsoriasisClinical trial
A Phase 3, Randomised, Investigator-blind, Active-controlled, Parallel Group, Multicentre Trial Comparing the Efficacy and Safety of 4-weeks Treatment With LEO 90100 and Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque PsoriasisStatus: Completed, Estimated PCD: 2024-02-23